Nanalysis Scientific Corp. (TSXV:NSCI)

Market Cap	30.57M
Revenue (ttm)	45.50M
Net Income (ttm)	-13.61M
Shares Out	113.22M
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	62,312
Average Volume	50,660
Open	0.2550
Previous Close	0.2550
Day's Range	0.2550 - 0.2750
52-Week Range	0.2500 - 0.4850
Beta	0.44
RSI	43.98
Earnings Date	Apr 30, 2025

About Nanalysis Scientific

Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; 60-NMR platform; 100-NMR platform; 60-TEACH Platform; QUAD NMR Console; and Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides softwa...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• CEO: Sean Krakiwsky
• Employees: 249
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: NSCI

Financial Performance

In 2024, Nanalysis Scientific's revenue was 45.50 million, an increase of 59.82% compared to the previous year's 28.47 million. Losses were -13.61 million, -15.95% less than in 2023.